Review



tcd device  (Hitachi Ltd)


Bioz Verified Symbol Hitachi Ltd is a verified supplier
Bioz Manufacturer Symbol Hitachi Ltd manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Hitachi Ltd tcd device
    Fig. 3. Efficacy of scaled-up <t>TCD</t> <t>device</t> for microbial inactivation. (A) Schematic of microbial inactivation process using the scaled-up TCD device, where aerosols containing bacteria or viruses are dispersed on the device surface after charge injection. (B) Microbial inactivation efficiency for different model microorganisms [E. coli (gram-negative bacterium), B. subtilis (gram-positive bacterium), and MS2 bacteriophage (virus)]. (C) Effect of graphene on the microbial inactivation efficiency. No charg- ing voltage is applied to the device. (D) Effect of charging voltage on microbial inactivation efficiency. (E) Images showing the concentration of E. coli (left), B. subtilis (middle), and MS2 (right) at charging voltages of 20 and 1 V using the scaled-up TCD device. (F) Effect of humidity (up to 90%) and temperature (up to 60°C) on the effi- cacy of the TCD device for E. coli inactivation after 48 and 72 hours. (G) Efficacy of TCD device for bacterial inactivation when treating intermittently applied aerosols containing E. coli or B. subtilis. In (B) to (E), the experiment is performed at a fixed temperature (20°C) and humidity (30%). In (E) to (G), the TCD device is charged to 10 V, and microorganisms are measured after 1 min of attachment. Dashed lines indicate that all microorganisms are inactivated (i.e., no live microorganisms detected). Error bars represent SD (n = 3). Significant differences among groups are indicated by * and ** for P < 0.05 and P < 0.01, respectively.
    Tcd Device, supplied by Hitachi Ltd, used in various techniques. Bioz Stars score: 99/100, based on 147615 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tcd+device/pm38701201-179-12-19?v=Hitachi+Ltd
    Average 99 stars, based on 147615 article reviews
    tcd device - by Bioz Stars, 2026-07
    99/100 stars

    Images

    1) Product Images from "Highly efficient microbial inactivation enabled by tunneling charges injected through two-dimensional electronics."

    Article Title: Highly efficient microbial inactivation enabled by tunneling charges injected through two-dimensional electronics.

    Journal: Science advances

    doi: 10.1126/sciadv.adl5067

    Fig. 3. Efficacy of scaled-up TCD device for microbial inactivation. (A) Schematic of microbial inactivation process using the scaled-up TCD device, where aerosols containing bacteria or viruses are dispersed on the device surface after charge injection. (B) Microbial inactivation efficiency for different model microorganisms [E. coli (gram-negative bacterium), B. subtilis (gram-positive bacterium), and MS2 bacteriophage (virus)]. (C) Effect of graphene on the microbial inactivation efficiency. No charg- ing voltage is applied to the device. (D) Effect of charging voltage on microbial inactivation efficiency. (E) Images showing the concentration of E. coli (left), B. subtilis (middle), and MS2 (right) at charging voltages of 20 and 1 V using the scaled-up TCD device. (F) Effect of humidity (up to 90%) and temperature (up to 60°C) on the effi- cacy of the TCD device for E. coli inactivation after 48 and 72 hours. (G) Efficacy of TCD device for bacterial inactivation when treating intermittently applied aerosols containing E. coli or B. subtilis. In (B) to (E), the experiment is performed at a fixed temperature (20°C) and humidity (30%). In (E) to (G), the TCD device is charged to 10 V, and microorganisms are measured after 1 min of attachment. Dashed lines indicate that all microorganisms are inactivated (i.e., no live microorganisms detected). Error bars represent SD (n = 3). Significant differences among groups are indicated by * and ** for P < 0.05 and P < 0.01, respectively.
    Figure Legend Snippet: Fig. 3. Efficacy of scaled-up TCD device for microbial inactivation. (A) Schematic of microbial inactivation process using the scaled-up TCD device, where aerosols containing bacteria or viruses are dispersed on the device surface after charge injection. (B) Microbial inactivation efficiency for different model microorganisms [E. coli (gram-negative bacterium), B. subtilis (gram-positive bacterium), and MS2 bacteriophage (virus)]. (C) Effect of graphene on the microbial inactivation efficiency. No charg- ing voltage is applied to the device. (D) Effect of charging voltage on microbial inactivation efficiency. (E) Images showing the concentration of E. coli (left), B. subtilis (middle), and MS2 (right) at charging voltages of 20 and 1 V using the scaled-up TCD device. (F) Effect of humidity (up to 90%) and temperature (up to 60°C) on the effi- cacy of the TCD device for E. coli inactivation after 48 and 72 hours. (G) Efficacy of TCD device for bacterial inactivation when treating intermittently applied aerosols containing E. coli or B. subtilis. In (B) to (E), the experiment is performed at a fixed temperature (20°C) and humidity (30%). In (E) to (G), the TCD device is charged to 10 V, and microorganisms are measured after 1 min of attachment. Dashed lines indicate that all microorganisms are inactivated (i.e., no live microorganisms detected). Error bars represent SD (n = 3). Significant differences among groups are indicated by * and ** for P < 0.05 and P < 0.01, respectively.

    Techniques Used: Bacteria, Injection, Virus, Concentration Assay

    Fig. 4. Investigation of antimicrobial mechanism of TCD device. (A) SEM images of bacteria (E. coli; top) and TEM images of virus (MS2; bottom) before and after attach- ment to TCD. (B) Fluorescence microscopy showing bright-field (total bacteria) and fluorescence (membrane-damaged bacteria) images of E. coli before (top) and after (bottom) attachment to TCD. (C) Change in membrane permeability of E. coli and B. subtilis (top) and percentage of bacteria with damaged membrane structures (bottom) after attachment to TCD at different charging voltages (1 to 20 V). (D) Intracellular generation of ROS after attachment to TCD. (E) Activity of bacterial superoxide dis- mutase enzyme. (F) Activity of bacterial antioxidant enzymes. (G) Intracellular adenosine 5′-triphosphate (ATP) levels in TCD-treated bacteria. (H) Expression of key genes related to ROS production and DNA integration/repair. Microorganisms were evaluated after 1 min of attachment. In (A), (B), and (D) to (H), the TCD device is charged to 10 V. The experiment is performed at a fixed temperature (20°C) and humidity (30%). Error bars represent SD (n = 3). Significant differences among groups are indicated by * and ** for P < 0.05 and P < 0.01, respectively.
    Figure Legend Snippet: Fig. 4. Investigation of antimicrobial mechanism of TCD device. (A) SEM images of bacteria (E. coli; top) and TEM images of virus (MS2; bottom) before and after attach- ment to TCD. (B) Fluorescence microscopy showing bright-field (total bacteria) and fluorescence (membrane-damaged bacteria) images of E. coli before (top) and after (bottom) attachment to TCD. (C) Change in membrane permeability of E. coli and B. subtilis (top) and percentage of bacteria with damaged membrane structures (bottom) after attachment to TCD at different charging voltages (1 to 20 V). (D) Intracellular generation of ROS after attachment to TCD. (E) Activity of bacterial superoxide dis- mutase enzyme. (F) Activity of bacterial antioxidant enzymes. (G) Intracellular adenosine 5′-triphosphate (ATP) levels in TCD-treated bacteria. (H) Expression of key genes related to ROS production and DNA integration/repair. Microorganisms were evaluated after 1 min of attachment. In (A), (B), and (D) to (H), the TCD device is charged to 10 V. The experiment is performed at a fixed temperature (20°C) and humidity (30%). Error bars represent SD (n = 3). Significant differences among groups are indicated by * and ** for P < 0.05 and P < 0.01, respectively.

    Techniques Used: Bacteria, Virus, Fluorescence, Microscopy, Membrane, Permeability, Activity Assay, Expressing

    Fig. 5. Antimicrobial mechanism of TCD device and its potential application. (A and B) Schematic illustration of bacterial (A) and viral (B) inactivation mechanisms involved in the TCD process based on electron transfer. (C) Potential application scenario of the TCD device on high-touch surfaces in indoor environments (e.g., elevator buttons and armrests in hospitals). (D) Unique properties (reliability and robustness) of the TCD device for microbial inactivation in practical applications.
    Figure Legend Snippet: Fig. 5. Antimicrobial mechanism of TCD device and its potential application. (A and B) Schematic illustration of bacterial (A) and viral (B) inactivation mechanisms involved in the TCD process based on electron transfer. (C) Potential application scenario of the TCD device on high-touch surfaces in indoor environments (e.g., elevator buttons and armrests in hospitals). (D) Unique properties (reliability and robustness) of the TCD device for microbial inactivation in practical applications.

    Techniques Used:



    Similar Products

    99
    Hitachi Ltd tcd device
    Fig. 3. Efficacy of scaled-up <t>TCD</t> <t>device</t> for microbial inactivation. (A) Schematic of microbial inactivation process using the scaled-up TCD device, where aerosols containing bacteria or viruses are dispersed on the device surface after charge injection. (B) Microbial inactivation efficiency for different model microorganisms [E. coli (gram-negative bacterium), B. subtilis (gram-positive bacterium), and MS2 bacteriophage (virus)]. (C) Effect of graphene on the microbial inactivation efficiency. No charg- ing voltage is applied to the device. (D) Effect of charging voltage on microbial inactivation efficiency. (E) Images showing the concentration of E. coli (left), B. subtilis (middle), and MS2 (right) at charging voltages of 20 and 1 V using the scaled-up TCD device. (F) Effect of humidity (up to 90%) and temperature (up to 60°C) on the effi- cacy of the TCD device for E. coli inactivation after 48 and 72 hours. (G) Efficacy of TCD device for bacterial inactivation when treating intermittently applied aerosols containing E. coli or B. subtilis. In (B) to (E), the experiment is performed at a fixed temperature (20°C) and humidity (30%). In (E) to (G), the TCD device is charged to 10 V, and microorganisms are measured after 1 min of attachment. Dashed lines indicate that all microorganisms are inactivated (i.e., no live microorganisms detected). Error bars represent SD (n = 3). Significant differences among groups are indicated by * and ** for P < 0.05 and P < 0.01, respectively.
    Tcd Device, supplied by Hitachi Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tcd+device/pm38701201-179-12-19?v=Hitachi+Ltd
    Average 99 stars, based on 1 article reviews
    tcd device - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    90
    Compumedics tcd device doppler-boxx
    Fig. 3. Efficacy of scaled-up <t>TCD</t> <t>device</t> for microbial inactivation. (A) Schematic of microbial inactivation process using the scaled-up TCD device, where aerosols containing bacteria or viruses are dispersed on the device surface after charge injection. (B) Microbial inactivation efficiency for different model microorganisms [E. coli (gram-negative bacterium), B. subtilis (gram-positive bacterium), and MS2 bacteriophage (virus)]. (C) Effect of graphene on the microbial inactivation efficiency. No charg- ing voltage is applied to the device. (D) Effect of charging voltage on microbial inactivation efficiency. (E) Images showing the concentration of E. coli (left), B. subtilis (middle), and MS2 (right) at charging voltages of 20 and 1 V using the scaled-up TCD device. (F) Effect of humidity (up to 90%) and temperature (up to 60°C) on the effi- cacy of the TCD device for E. coli inactivation after 48 and 72 hours. (G) Efficacy of TCD device for bacterial inactivation when treating intermittently applied aerosols containing E. coli or B. subtilis. In (B) to (E), the experiment is performed at a fixed temperature (20°C) and humidity (30%). In (E) to (G), the TCD device is charged to 10 V, and microorganisms are measured after 1 min of attachment. Dashed lines indicate that all microorganisms are inactivated (i.e., no live microorganisms detected). Error bars represent SD (n = 3). Significant differences among groups are indicated by * and ** for P < 0.05 and P < 0.01, respectively.
    Tcd Device Doppler Boxx, supplied by Compumedics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tcd+device/pm40586368-58-15-19?v=Compumedics
    Average 90 stars, based on 1 article reviews
    tcd device doppler-boxx - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Spencer Technologies Inc tcd device
    Fig. 3. Efficacy of scaled-up <t>TCD</t> <t>device</t> for microbial inactivation. (A) Schematic of microbial inactivation process using the scaled-up TCD device, where aerosols containing bacteria or viruses are dispersed on the device surface after charge injection. (B) Microbial inactivation efficiency for different model microorganisms [E. coli (gram-negative bacterium), B. subtilis (gram-positive bacterium), and MS2 bacteriophage (virus)]. (C) Effect of graphene on the microbial inactivation efficiency. No charg- ing voltage is applied to the device. (D) Effect of charging voltage on microbial inactivation efficiency. (E) Images showing the concentration of E. coli (left), B. subtilis (middle), and MS2 (right) at charging voltages of 20 and 1 V using the scaled-up TCD device. (F) Effect of humidity (up to 90%) and temperature (up to 60°C) on the effi- cacy of the TCD device for E. coli inactivation after 48 and 72 hours. (G) Efficacy of TCD device for bacterial inactivation when treating intermittently applied aerosols containing E. coli or B. subtilis. In (B) to (E), the experiment is performed at a fixed temperature (20°C) and humidity (30%). In (E) to (G), the TCD device is charged to 10 V, and microorganisms are measured after 1 min of attachment. Dashed lines indicate that all microorganisms are inactivated (i.e., no live microorganisms detected). Error bars represent SD (n = 3). Significant differences among groups are indicated by * and ** for P < 0.05 and P < 0.01, respectively.
    Tcd Device, supplied by Spencer Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tcd+device/pmc11620822-116-21-21?v=Spencer+Technologies+Inc
    Average 90 stars, based on 1 article reviews
    tcd device - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Toshiba America Electronic Components Inc oneline charge couple device (ccd) toshiba tcd 1304 ap
    Fig. 3. Efficacy of scaled-up <t>TCD</t> <t>device</t> for microbial inactivation. (A) Schematic of microbial inactivation process using the scaled-up TCD device, where aerosols containing bacteria or viruses are dispersed on the device surface after charge injection. (B) Microbial inactivation efficiency for different model microorganisms [E. coli (gram-negative bacterium), B. subtilis (gram-positive bacterium), and MS2 bacteriophage (virus)]. (C) Effect of graphene on the microbial inactivation efficiency. No charg- ing voltage is applied to the device. (D) Effect of charging voltage on microbial inactivation efficiency. (E) Images showing the concentration of E. coli (left), B. subtilis (middle), and MS2 (right) at charging voltages of 20 and 1 V using the scaled-up TCD device. (F) Effect of humidity (up to 90%) and temperature (up to 60°C) on the effi- cacy of the TCD device for E. coli inactivation after 48 and 72 hours. (G) Efficacy of TCD device for bacterial inactivation when treating intermittently applied aerosols containing E. coli or B. subtilis. In (B) to (E), the experiment is performed at a fixed temperature (20°C) and humidity (30%). In (E) to (G), the TCD device is charged to 10 V, and microorganisms are measured after 1 min of attachment. Dashed lines indicate that all microorganisms are inactivated (i.e., no live microorganisms detected). Error bars represent SD (n = 3). Significant differences among groups are indicated by * and ** for P < 0.05 and P < 0.01, respectively.
    Oneline Charge Couple Device (Ccd) Toshiba Tcd 1304 Ap, supplied by Toshiba America Electronic Components Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tcd+device/10__1063_slash_5__0228803-44-4-9?v=Toshiba+America+Electronic+Components+Inc
    Average 90 stars, based on 1 article reviews
    oneline charge couple device (ccd) toshiba tcd 1304 ap - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Compumedics dwl doppler box digital tcd device
    The <t>TCD</t> study protocol. This protocol was performed within 48h of stroke onset, again between 3 and 7 days for participants with stroke, and once for controls. TCD, <t>transcranial</t> <t>Doppler</t> ultrasound; MCA, middle cerebral artery; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; O 2 , Oxygen saturation.
    Dwl Doppler Box Digital Tcd Device, supplied by Compumedics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tcd+device/pmc11269199-111-19-18?v=Compumedics
    Average 90 stars, based on 1 article reviews
    dwl doppler box digital tcd device - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Compumedics digital dwl® tcd device
    The <t>TCD</t> study protocol. This protocol was performed within 48h of stroke onset, again between 3 and 7 days for participants with stroke, and once for controls. TCD, <t>transcranial</t> <t>Doppler</t> ultrasound; MCA, middle cerebral artery; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; O 2 , Oxygen saturation.
    Digital Dwl® Tcd Device, supplied by Compumedics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tcd+device/pmc10909929-72-7-17?v=Compumedics
    Average 90 stars, based on 1 article reviews
    digital dwl® tcd device - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Compumedics tcd device doppler-box
    The <t>TCD</t> study protocol. This protocol was performed within 48h of stroke onset, again between 3 and 7 days for participants with stroke, and once for controls. TCD, <t>transcranial</t> <t>Doppler</t> ultrasound; MCA, middle cerebral artery; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; O 2 , Oxygen saturation.
    Tcd Device Doppler Box, supplied by Compumedics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tcd+device/pm38002559-81-1-5?v=Compumedics
    Average 90 stars, based on 1 article reviews
    tcd device doppler-box - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    MicrotracBEL gmbh chemisorption device equipped with a thermal conductivity detector (tcd)
    The <t>TCD</t> study protocol. This protocol was performed within 48h of stroke onset, again between 3 and 7 days for participants with stroke, and once for controls. TCD, <t>transcranial</t> <t>Doppler</t> ultrasound; MCA, middle cerebral artery; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; O 2 , Oxygen saturation.
    Chemisorption Device Equipped With A Thermal Conductivity Detector (Tcd), supplied by MicrotracBEL gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tcd+device/10__1016_slash_j__cattod__2023__01__005-94-13-13?v=MicrotracBEL+gmbh
    Average 90 stars, based on 1 article reviews
    chemisorption device equipped with a thermal conductivity detector (tcd) - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Spencer Technologies Inc tcd monitoring device (pmd 150;
    The <t>TCD</t> study protocol. This protocol was performed within 48h of stroke onset, again between 3 and 7 days for participants with stroke, and once for controls. TCD, <t>transcranial</t> <t>Doppler</t> ultrasound; MCA, middle cerebral artery; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; O 2 , Oxygen saturation.
    Tcd Monitoring Device (Pmd 150;, supplied by Spencer Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tcd+device/pm37667457-89-8-13?v=Spencer+Technologies+Inc
    Average 90 stars, based on 1 article reviews
    tcd monitoring device (pmd 150; - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Philips Healthcare tcd device sonos 7500
    The <t>TCD</t> study protocol. This protocol was performed within 48h of stroke onset, again between 3 and 7 days for participants with stroke, and once for controls. TCD, <t>transcranial</t> <t>Doppler</t> ultrasound; MCA, middle cerebral artery; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; O 2 , Oxygen saturation.
    Tcd Device Sonos 7500, supplied by Philips Healthcare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tcd+device/nct05543837-9-4-6?v=Philips+Healthcare
    Average 90 stars, based on 1 article reviews
    tcd device sonos 7500 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 3. Efficacy of scaled-up TCD device for microbial inactivation. (A) Schematic of microbial inactivation process using the scaled-up TCD device, where aerosols containing bacteria or viruses are dispersed on the device surface after charge injection. (B) Microbial inactivation efficiency for different model microorganisms [E. coli (gram-negative bacterium), B. subtilis (gram-positive bacterium), and MS2 bacteriophage (virus)]. (C) Effect of graphene on the microbial inactivation efficiency. No charg- ing voltage is applied to the device. (D) Effect of charging voltage on microbial inactivation efficiency. (E) Images showing the concentration of E. coli (left), B. subtilis (middle), and MS2 (right) at charging voltages of 20 and 1 V using the scaled-up TCD device. (F) Effect of humidity (up to 90%) and temperature (up to 60°C) on the effi- cacy of the TCD device for E. coli inactivation after 48 and 72 hours. (G) Efficacy of TCD device for bacterial inactivation when treating intermittently applied aerosols containing E. coli or B. subtilis. In (B) to (E), the experiment is performed at a fixed temperature (20°C) and humidity (30%). In (E) to (G), the TCD device is charged to 10 V, and microorganisms are measured after 1 min of attachment. Dashed lines indicate that all microorganisms are inactivated (i.e., no live microorganisms detected). Error bars represent SD (n = 3). Significant differences among groups are indicated by * and ** for P < 0.05 and P < 0.01, respectively.

    Journal: Science advances

    Article Title: Highly efficient microbial inactivation enabled by tunneling charges injected through two-dimensional electronics.

    doi: 10.1126/sciadv.adl5067

    Figure Lengend Snippet: Fig. 3. Efficacy of scaled-up TCD device for microbial inactivation. (A) Schematic of microbial inactivation process using the scaled-up TCD device, where aerosols containing bacteria or viruses are dispersed on the device surface after charge injection. (B) Microbial inactivation efficiency for different model microorganisms [E. coli (gram-negative bacterium), B. subtilis (gram-positive bacterium), and MS2 bacteriophage (virus)]. (C) Effect of graphene on the microbial inactivation efficiency. No charg- ing voltage is applied to the device. (D) Effect of charging voltage on microbial inactivation efficiency. (E) Images showing the concentration of E. coli (left), B. subtilis (middle), and MS2 (right) at charging voltages of 20 and 1 V using the scaled-up TCD device. (F) Effect of humidity (up to 90%) and temperature (up to 60°C) on the effi- cacy of the TCD device for E. coli inactivation after 48 and 72 hours. (G) Efficacy of TCD device for bacterial inactivation when treating intermittently applied aerosols containing E. coli or B. subtilis. In (B) to (E), the experiment is performed at a fixed temperature (20°C) and humidity (30%). In (E) to (G), the TCD device is charged to 10 V, and microorganisms are measured after 1 min of attachment. Dashed lines indicate that all microorganisms are inactivated (i.e., no live microorganisms detected). Error bars represent SD (n = 3). Significant differences among groups are indicated by * and ** for P < 0.05 and P < 0.01, respectively.

    Article Snippet: The morphology of the E. coli before and after attachment to the TCD device was evaluated using SEM (SU8230, Hitachi).

    Techniques: Bacteria, Injection, Virus, Concentration Assay

    Fig. 4. Investigation of antimicrobial mechanism of TCD device. (A) SEM images of bacteria (E. coli; top) and TEM images of virus (MS2; bottom) before and after attach- ment to TCD. (B) Fluorescence microscopy showing bright-field (total bacteria) and fluorescence (membrane-damaged bacteria) images of E. coli before (top) and after (bottom) attachment to TCD. (C) Change in membrane permeability of E. coli and B. subtilis (top) and percentage of bacteria with damaged membrane structures (bottom) after attachment to TCD at different charging voltages (1 to 20 V). (D) Intracellular generation of ROS after attachment to TCD. (E) Activity of bacterial superoxide dis- mutase enzyme. (F) Activity of bacterial antioxidant enzymes. (G) Intracellular adenosine 5′-triphosphate (ATP) levels in TCD-treated bacteria. (H) Expression of key genes related to ROS production and DNA integration/repair. Microorganisms were evaluated after 1 min of attachment. In (A), (B), and (D) to (H), the TCD device is charged to 10 V. The experiment is performed at a fixed temperature (20°C) and humidity (30%). Error bars represent SD (n = 3). Significant differences among groups are indicated by * and ** for P < 0.05 and P < 0.01, respectively.

    Journal: Science advances

    Article Title: Highly efficient microbial inactivation enabled by tunneling charges injected through two-dimensional electronics.

    doi: 10.1126/sciadv.adl5067

    Figure Lengend Snippet: Fig. 4. Investigation of antimicrobial mechanism of TCD device. (A) SEM images of bacteria (E. coli; top) and TEM images of virus (MS2; bottom) before and after attach- ment to TCD. (B) Fluorescence microscopy showing bright-field (total bacteria) and fluorescence (membrane-damaged bacteria) images of E. coli before (top) and after (bottom) attachment to TCD. (C) Change in membrane permeability of E. coli and B. subtilis (top) and percentage of bacteria with damaged membrane structures (bottom) after attachment to TCD at different charging voltages (1 to 20 V). (D) Intracellular generation of ROS after attachment to TCD. (E) Activity of bacterial superoxide dis- mutase enzyme. (F) Activity of bacterial antioxidant enzymes. (G) Intracellular adenosine 5′-triphosphate (ATP) levels in TCD-treated bacteria. (H) Expression of key genes related to ROS production and DNA integration/repair. Microorganisms were evaluated after 1 min of attachment. In (A), (B), and (D) to (H), the TCD device is charged to 10 V. The experiment is performed at a fixed temperature (20°C) and humidity (30%). Error bars represent SD (n = 3). Significant differences among groups are indicated by * and ** for P < 0.05 and P < 0.01, respectively.

    Article Snippet: The morphology of the E. coli before and after attachment to the TCD device was evaluated using SEM (SU8230, Hitachi).

    Techniques: Bacteria, Virus, Fluorescence, Microscopy, Membrane, Permeability, Activity Assay, Expressing

    Fig. 5. Antimicrobial mechanism of TCD device and its potential application. (A and B) Schematic illustration of bacterial (A) and viral (B) inactivation mechanisms involved in the TCD process based on electron transfer. (C) Potential application scenario of the TCD device on high-touch surfaces in indoor environments (e.g., elevator buttons and armrests in hospitals). (D) Unique properties (reliability and robustness) of the TCD device for microbial inactivation in practical applications.

    Journal: Science advances

    Article Title: Highly efficient microbial inactivation enabled by tunneling charges injected through two-dimensional electronics.

    doi: 10.1126/sciadv.adl5067

    Figure Lengend Snippet: Fig. 5. Antimicrobial mechanism of TCD device and its potential application. (A and B) Schematic illustration of bacterial (A) and viral (B) inactivation mechanisms involved in the TCD process based on electron transfer. (C) Potential application scenario of the TCD device on high-touch surfaces in indoor environments (e.g., elevator buttons and armrests in hospitals). (D) Unique properties (reliability and robustness) of the TCD device for microbial inactivation in practical applications.

    Article Snippet: The morphology of the E. coli before and after attachment to the TCD device was evaluated using SEM (SU8230, Hitachi).

    Techniques:

    The TCD study protocol. This protocol was performed within 48h of stroke onset, again between 3 and 7 days for participants with stroke, and once for controls. TCD, transcranial Doppler ultrasound; MCA, middle cerebral artery; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; O 2 , Oxygen saturation.

    Journal: Frontiers in Neurology

    Article Title: Cerebral hemodynamic response to upright position in acute ischemic stroke

    doi: 10.3389/fneur.2024.1392773

    Figure Lengend Snippet: The TCD study protocol. This protocol was performed within 48h of stroke onset, again between 3 and 7 days for participants with stroke, and once for controls. TCD, transcranial Doppler ultrasound; MCA, middle cerebral artery; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; O 2 , Oxygen saturation.

    Article Snippet: MCA signals (peak systolic and end-diastolic velocities) were located bilaterally at a depth of 55 mm using a Compumedics DWL Doppler Box digital TCD device.

    Techniques: